SCYNEXIS, Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
SCYNEXIS, Inc. (SCYX) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2016-03-07
- SCYNEXIS, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-09-30 was 0.00 shares.
- SCYNEXIS, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2014-09-30 was 0.00 shares.
- SCYNEXIS, Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2015 was 0.00 shares, a 100.00% decline from fiscal 2014.
- SCYNEXIS, Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2014 was 273.78K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2015-12-31 | 0.00 shares 10-K · filed 2016-03-07 | |||
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-13 | 0.00 shares 10-Q · filed 2015-11-13 | ||
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-19 | 0.00 shares 10-Q · filed 2015-08-19 | ||
| 2015-03-31 | 0.00 shares 8-K · filed 2015-10-30 | |||
| 2014-12-31 | 273.78K shares 10-K · filed 2016-03-07 | |||
| 2014-09-30 | 0.00 shares 10-Q · filed 2015-11-13 | 273.69K shares 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | 273.20K shares 10-Q · filed 2015-08-19 | 273.71K shares 10-Q · filed 2015-08-19 | ||
| 2014-03-31 | 274.99K shares 8-K · filed 2015-10-30 | |||
| 2013-12-31 | 0.00 shares 8-K · filed 2015-10-30 | |||
| 2013-09-30 | 0.00 shares 10-Q · filed 2014-11-13 | 0.00 shares 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |